Naomi Martin
- Rheumatology top 5%
- Neurology top 10%
- Genetics top 10%
- Hematology top 10%
- Immunology
- Co-authors
- Lisa CipolottiAileen L. PanganBoulos HaraouiMaureen RischmuellerAndrea Rubbert‐RothJeffrey EnejosaRicardo Machado XavierYing Zhang
- Topics
- Rheumatoid Arthritis Research and Therapies (8 papers)Chronic Lymphocytic Leukemia Research (6 papers)Autoimmune and Inflammatory Disorders Research (5 papers)
- Cited by
- RheumatologyGeneticsNeurology
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Naomi Martin
20 papers receiving 474 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Rheumatology 175
- Neurology 146
- Genetics 112
- Hematology 78
- Immunology 60
Countries citing papers authored by Naomi Martin
This map shows the geographic impact of Naomi Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Martin more than expected).
Fields of papers citing papers by Naomi Martin
This network shows the impact of papers produced by Naomi Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Martin. The network helps show where Naomi Martin may publish in the future.
Co-authorship network of co-authors of Naomi Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Martin. A scholar is included among the top collaborators of Naomi Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Martin. Naomi Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 14 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | Trial of Upadacitinib or Abatacept in Rheumatoid Arthritisbreakdown → | 181 |
| 12 | 15 | |
| 13 | 41 | |
| 14 | 44 | |
| 15 | 14 | |
| 16 | 12 | |
| 17 | 1 | |
| 18 | 10 | |
| 19 | 72 | |
| 20 | 42 |
About Naomi Martin
Naomi Martin is a scholar working on Genetics, Health Informatics and Hematology, having authored 21 papers that have together received 483 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). The work is most often cited by research in Rheumatology (175 citations), Genetics (112 citations) and Neurology (146 citations). Naomi Martin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lisa Cipolotti, Aileen L. Pangan, Boulos Haraoui, Maureen Rischmueller, Andrea Rubbert‐Roth, Jeffrey Enejosa, Ricardo Machado Xavier, Ying Zhang, Nasser Khan and Paola Giunti. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.